Evidence map›Paper›PMID 25973017›Full record

ArticleInternational journal of clinical and experimental pathology2015

MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.

Jun Qin, Feiran Wang, Haiyan Jiang, Junfei Xu, Yasu Jiang, Zhiwei Wang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jun QinDepartment of General Surgery, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Feiran WangDepartment of General Surgery, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Haiyan JiangMedical College of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Junfei XuDepartment of General Surgery, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Yasu JiangDepartment of General Surgery, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Zhiwei WangDepartment of General Surgery, Affiliated Hospital of Nantong University Nantong 226001, Jiangsu Province, P. R. China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of cancers show increased expression of paxillin which plays a central role in tumor progression, including colorectal cancer. However, the mechanisms causing paxillin upregulation remains unclear. In our study, bioinformatics analyses suggested that paxillin is predicted to be a direct target of miR-145. We firstly identified paxillin as a new target of miR-145 and demonstrated that miR-145 inhibits paxillin expression by binding to the paxillin mRNA 3'UTR. Therefore, we assume overexpression of paxillin induced by suppression of miR-145 may promote cell migration and invasion. We detected the expression of paxillin and miR-145 in human colorectal cancer tissues by real-time quantitative PCR. Higher expression of paxillin and lower expression of miR-145 was observed in colorectal cancer tissues than corresponding paracancerous tissue. Moreover, the expression of paxillin was negatively correlated with miR-145 expression. A dual-luciferase reporter assay was used to confirm that paxillin was a direct target of miR-145. In CRC cell lines, overexpression of miR-145 could downregulate paxillin protein expression levels, and ectopic overexpression of miR-145 mimics or inhibitor could inhibit or promote cell migration, invasion, proliferation and clone formation in vitro. Taken together, these data suggested that miR-145 plays a pivotal role in colon cancer through inhibiting cell proliferation migration and invasion, and miR-145 may serve as a tumor suppressor by targeting paxillin gene.

Indexed as

Cell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsDown-RegulationGene Expression Regulation, NeoplasticHumansMicroRNAsNeoplasm InvasivenessPaxillinMicroRNAsMIRN145 microRNA, humanPaxillincolorectal cancermigrationmiR-145paxillinproliferation

Identifiers

PMID25973017
PMCPMC4396207
OpenAlexW2426858060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.